Back
ESC2025 Premium Access

The efficacy and safety of edoxaban compared to warfarin in patients with atrial fibrillation with different clinical phenotypes: a meta-analysis of randomized controlled trials

Session: Anticoagulation in atrial fibrillation: real-world experience
Topic: Oral Anticoagulation
Speaker: Doctor T. Chao (Taipei, TW)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
5 presentations
0 follower

6 more presentations in this session

Balancing safety and efficacy: Factor XIa inhibitors vs. DOACs in atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials

Speaker: Miss J. Khater (Beirut, LB)

Access
Abstract
Slides
Video
Like
Thumbnail

Real-world outcomes of oral anticoagulation in atrial fibrillation patients with high bleeding and stroke risks: evidence from three international registries from Middle East, Europe and Asia-Pacific

Speaker: Doctor A. Askarinejad (Liverpool, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Analysis of left atrial thrombus in atrial flutter and atrial fibrillation

Speaker: Professor M. Wybraniec (Katowice, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Risk of adverse events in non-anticoagulated european and asian patients with atrial fibrillation and clinical complexity: an analysis from two prospective observational registries

Speaker: Doctor E. Tartaglia (Liverpool, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

10-year trend of antithrombotic therapy status and clinical outcomes of young patients with atrial fibrillation The Fushimi AF Registry

Speaker: Doctor N. Masunaga (Kyoto, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Anticoagulation in atrial fibrillation: real-world experience

Speakers: Doctor T. Chao, Miss J. Khater, Doctor A. Askarinejad, Professor M. Wybraniec, Doctor E. Tartaglia...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources